Exploring Potential Drug-Drug Interactions: A Cross-Sectional Study of 1 Million e-Prescriptions Across Medical Specialties in Shiraz, Iran (2021-2024). [PDF]
Porbaha P +5 more
europepmc +1 more source
Scratching the surface: NK-1 inhibitors for chronic itch-Promise or placebo? [PDF]
Yosipovitch G.
europepmc +1 more source
Anti-Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin-1 Pathway. [PDF]
Engür-Öztürk S +2 more
europepmc +1 more source
doctoral医学系研究科The pharmacokinetics of aprepitant, a neurokinin-1 receptor antagonist, have not been fully evaluated in clinical settings. The aim of this study was to characterize the plasma pharmacokinetics of aprepitant and reveal their influence of ...
Motohashi, Shinya
core
Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas. [PDF]
Lopez AG +14 more
europepmc +1 more source
Structure-Based Virtual Screening and Mechanistic Characterization of Methotrexate and Selinexor as Potent Anti-Melanogenic Agents via Multi-Pathway Suppression of MITF. [PDF]
Zhang Z +5 more
europepmc +1 more source
Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitors. [PDF]
Yoo H +8 more
europepmc +1 more source
Neuro-immune-epithelial pathways involving substance P may contribute to mucosal pathology in gastro-oesophageal reflux disease. [PDF]
Leech T, Woodland P, Peiris M.
europepmc +1 more source
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]
Navari RM +7 more
europepmc +1 more source
Neural signaling contributes to heart formation and growth in the invertebrate chordate, Ciona robusta. [PDF]
Gruner HN +21 more
europepmc +1 more source

